Research Article

Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer's Disease Treatment

Volume: 27 Number: Ek Sayı 1 (Suppl 1) December 25, 2024
TR EN

Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer's Disease Treatment

Abstract

Alzheimer’s Disease (AD) is a debilitating neurodegenerative condition with limited treatment options. Lignans, a class of naturally occurring polyphenols found in various plants, have been shown to have the potential to modulate pathways associated with AD pathology. In this study, we used network pharmacology and molecular docking to investigate the therapeutic potential of lignans against AD by targeting specific proteins involved in disease progression. Our established interaction network includes key proteins such as EGFR, HSP90AA1, BCL2, HSP90AB1, IL6, JUN, ESR1, PIK3CA, ERBB2, and PIK3R1. Molecular docking studies have revealed how lignans interact with these proteins and highlighted their potential to influence AD through mechanisms such as inflammation modulation, apoptosis regulation, and signal transduction pathways. The results suggest that lignans have significant binding abilities to these targets, potentially inhibiting their activity and thus alleviating AD symptoms by reducing amyloid-beta accumulation and tau phosphorylation. These findings support the viability of lignans as a basis for the development of new AD therapies and call for further in vivo studies to confirm their efficacy and safety. This integrated approach underscores the value of combining network pharmacology and molecular docking in the search for new therapeutic agents against complex diseases such as AD.

Keywords

Ethical Statement

An ethics committee permission is not required for the article.

References

  1. Abadi, A.M., Zaki, M.S.A., Sideeg, A.M., El, A.F., & Guo, X. (2024). Determination of cytotoxicity, biological effects and anti-human breast cancer properties of Bilobol. Iranian Journal of Chemistry and Chemical Engineering (IJCCE), 1, 1-24.
  2. Abd El-Razek, M.H., Eissa, I.H., Al-Karmalawy, A.A., Elrashedy, A.A., El-Desoky, A.H., Aboelmagd, M., Mohamed, T.A., Hegazy, M.E.F. (2024). epi-Magnolin, a tetrahydrofurofuranoid lignan from the oleo-gum resin of Commiphora wightii, as inhibitor of pancreatic cancer cell proliferation, in-vitro and in-silico study. Journal of Biomolecular Structure and Dynamics, 1, 1-13.
  3. Abdul, H., Butterfield, D. (2007). Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Free Radical Biology & Medicine, 42(3), 371-84.
  4. Aguilar-Carrillo, Y., Soto-Urzúa, L., Martínez-Martínez, M.D.L.Á., Becerril-Ramírez, M., Martínez-Morales, L.J. (2024). Computational analysis of the tripartite interaction of phasins (PhaP4 and 5)-sigma factor (σ24)-DNA of Azospirillum brasilense Sp7. Polymers, 16(5), 611.
  5. Ahsan, A., Ramanand, S., Whitehead, C., Hiniker, S., Rehemtulla, A., Pratt, W., Jolly, S., Gouveia, C., Truong, K., Waes, C., Ray, D., Lawrence, T., Nyati, M. (2012). Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors. Neoplasia, 14(8),670-677 .
  6. Alam, M., Ali, S., Mohammad, T., Hasan, G.M., Yadav, D.K., Hassan, M.I. (2021). B cell lymphoma 2: a potential therapeutic target for cancer therapy. International Journal of Molecular Sciences, 22(19), 10442.
  7. Arjmandi-Rad, S., Vestergaard Nieland, J.D., Goozee, K.G., Vaseghi, S. (2024). The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer’s disease: A systematic review. Neurological Sciences, 45(2), 417-430.
  8. Astillero‐Lopez, V., Villar‐Conde, S., Gonzalez‐Rodriguez, M., Flores‐Cuadrado, A., Ubeda‐Banon, I., Saiz‐Sanchez, D., Martinez‐Marcos, A. (2024). Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells. Brain Pathology, e13235.

Details

Primary Language

English

Subjects

Pharmaceutical Botany

Journal Section

Research Article

Early Pub Date

September 15, 2024

Publication Date

December 25, 2024

Submission Date

May 27, 2024

Acceptance Date

August 14, 2024

Published in Issue

Year 2024 Volume: 27 Number: Ek Sayı 1 (Suppl 1)

APA
Şirin, S., & Niğdelioğlu Dolanbay, S. (2024). Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer’s Disease Treatment. Kahramanmaraş Sütçü İmam Üniversitesi Tarım Ve Doğa Dergisi, 27(Ek Sayı 1 (Suppl 1), 35-58. https://doi.org/10.18016/ksutarimdoga.vi.1490753

Cited By


International Peer Reviewed Journal
Free submission and publication
Published 6 times a year



88x31.png


KSU Journal of Agriculture and Nature

e-ISSN: 2619-9149